Transcobalamin I: a novel prognostic biomarker of neoadjuvant chemotherapy in locally advanced hypopharyngeal squamous cell cancers

BACKGROUND: Hypopharyngeal squamous cell carcinoma (HPSCC) is an aggressive head and neck squamous cell carcinoma with poor prognosis. Neoadjuvant chemotherapy (NACT) followed by concurrent chemoradiotherapy could provide better efficacy in HPSCC treatment. Identification of predictive biomarkers is...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Onco Targets Ther
Hlavní autoři: Wang, Ying, Yue, Changli, Fang, Jugao, Gong, Lili, Lian, Meng, Wang, Ru, Feng, Ling, Ma, Hongzhi, Ma, Zhihong, Liu, Honggang
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove Medical Press 2018
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6065467/
https://ncbi.nlm.nih.gov/pubmed/30100732
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S166514
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky